Authors: Bruggemann, M Droese, J Bolz, I Luth, P Pott, C von Neuhoff, N Scheuering, U Kneba, M

Citation: M. Bruggemann et al., Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR, LEUKEMIA, 14(8), 2000, pp. 1419-1425

Authors: Dreger, P Viehmann, K von Neuhoff, N Kruss, D Glass, B Kneba, M Mitsky, P Jopp, P Rautenberg, P Mills, B Schmitz, N

Citation: P. Dreger et al., A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia, EXP HEMATOL, 28(10), 2000, pp. 1187-1196

Authors: Dreger, P Glass, B Seyfarth, B Humpe, A Claviez, A von Neuhoff, N Suttorp, M Schoch, R Schmitz, N

Citation: P. Dreger et al., Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT, BONE MAR TR, 26(12), 2000, pp. 1361-1362

Authors: Dreger, P Viehmann, K von Neuhoff, N Glaubitz, T Petzoldt, O Glass, B Uharek, L Rautenberg, P Suttorp, M Mills, B Mitsky, P Schmitz, N

Citation: P. Dreger et al., Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery, BONE MAR TR, 24(2), 1999, pp. 153-161

Authors: Dreger, P Glass, B Kuse, R Sonnen, R von Neuhoff, N Bolouri, H Kneba, M Schmitz, N

Citation: P. Dreger et al., Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenstrom's macroglobulinaemia, BR J HAEM, 106(1), 1999, pp. 115-118